Chicago Equity Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Chicago Equity Partners’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-256,540	Closed	-$3.19M	–	830
2016 Q4	$3.19M	Buy	256,540 +158,940	+163%	+$1.91M	0.08%	245
2016 Q3	$1.34M	Buy	+97,600	New	+$980K	0.04%	382

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Chicago Equity Partners's ARIA Position: Q1 2017 in Review

Chicago Equity Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 256,540 shares — an estimated $3.19M sold.

Chicago Equity Partners first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $3.19M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Chicago Equity Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Chicago Equity Partners sold 256,540 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $3.19M.
Chicago Equity Partners first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
Chicago Equity Partners's Ariad Pharmaceuticals Inc position peaked at $3.19M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Chicago Equity Partners's 13F filing for Q1 2017, filed 2 May 2017.